The DOI matches its Crossref record; 490 of the 490 references it cites were found in a registry or an index.
Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance
Open accessAbstract
The tumor microenvironment (TME) is a complex and ever-changing “rogue organ” composed of its own blood supply, lymphatic and nervous systems, stroma, immune cells and extracellular matrix (ECM). These complex components, utilizing both benign and malignant cells, nurture the harsh, immunosuppressive and nutrient-deficient environment necessary for tumor cell growth, proliferation and phenotypic flexibility and variation. An important aspect of the TME is cellular crosstalk and cell-to-ECM communication. This interaction induces the release of soluble factors responsible for immune evasion and ECM remodeling, which further contribute to therapy resistance. Other aspects are the presence of exosomes contributed by both malignant and benign cells, circulating deregulated microRNAs and TME-specific metabolic patterns which further potentiate the progression and/or resistance to therapy. In addition to biochemical signaling, specific TME characteristics such as the hypoxic environment, metabolic derangements, and abnormal mechanical forces have been implicated in the development of treatment resistance. In this review, we will provide an overview of tumor microenvironmental composition, structure, and features that influence immune suppression and contribute to treatment resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 401–490 of 490
Ochs, K., Sahm, F., Opitz, C. A., Lanz, T. V., Oezen, I., Couraud, P., von Deimling, A., Wick, W., & Platten, M. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.09.011 · Cited by 99
Cross-talk within the tumor microenvironment mediates Th2-type inflammation in pancreatic cancer
Protti, M. P., & Monte, L. B. D. (2012) · OncoImmunology · doi:10.4161/onci.1.1.17939 · Cited by 97
Shen, J., Pan, J., Du, C., Si, W., Yao, M., Xu, L., Zheng, H., Xu, M., Chen, D., Wang, S., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.158 · Cited by 97
Reactive Oxygen Species, Metabolic Plasticity, and Drug Resistance in Cancer
Bhardwaj, V., & He, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103412 · Cited by 97
Progress toward Overcoming Hypoxia-Induced Resistance to Solid Tumor Therapy
Reginato, M., & Karakashev, S. (2015) · Cancer Management and Research · doi:10.2147/cmar.s58285 · Cited by 95
Influence of the neural microenvironment on prostate cancer
Coarfa, C., Florentin, D., Putluri, N., Ding, Y., Au, J., He, D., Ragheb, A. M., Frolov, A., Michailidis, G. C., Lee, M., et al. (2017) · The Prostate · doi:10.1002/pros.23454 · Cited by 95
Mari, L., Hoefnagel, S. J. M., Zito, D., van de Meent, M., Endert, P. V., Calpe, S., Sancho‐Serra, M. D. C., Heemskerk, M. H. M., van Laarhoven, H. W. M., Hulshof, M. C. C. M., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.06.030 · Cited by 94
Hou, X., Yuan, S., Zhao, D., Liu, X., & Wu, X. (2018) · Bioscience Reports · doi:10.1042/bsr20181476 · Cited by 94
Role of Microenvironment on the Fate of Disseminating Cancer Stem Cells
Ingangi, V., Minopoli, M., Ragone, C., Motti, M. L., & Carriero, M. V. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00082 · Cited by 91
Colangelo, T., Polcaro, G., Ziccardi, P., Pucci, B., Muccillo, L., Galgani, M., Fucci, A., Milone, M. R., Budillon, A., Santopaolo, M., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.28 · Cited by 89
Evidence for an antigen-driven humoral immune response in medullary ductal breast cancer.
Coronella, J. A., Telleman, P., Kingsbury, G. A., Truong, T., Hays, S. R., & Junghans, R. P. (2001) · PubMed · Cited by 88
Bielecka, Z. F., Czarnecka, A. M., Solarek, W., Kornakiewicz, A., & Szczylik, C. A. (2014) · Current Signal Transduction Therapy · doi:10.2174/1574362409666140206223014 · Cited by 88
Haqqani, A. S., Sandhu, J. K., & Birnboim, H. C. (2000) · Neoplasia · doi:10.1038/sj.neo.7900110 · Cited by 88
Retinal Pericytes Inhibit Activated T Cell Proliferation
Tu, Z., Li, Y., Smith, D. S., Sheibani, N., Huang, S., Kern, T. S., & Lin, F. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8008 · Cited by 87
Zhou, B., Chen, W., Wang, Y., Lin, Z., Zhang, D., Fan, S., & Li, J. (2014) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12172 · Cited by 87
Zhu, X., Han, T., Wang, X., Li, Y.-H., Yang, H., Luo, Y., Yin, G.-W., & Yao, Y. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.03.002 · Cited by 86
Powell, J., Mota, F., Steadman, D., Soudy, C., Miyauchi, J. T., Crosby, S. R., Jarvis, A., Reisinger, T., Winfield, N., Evans, G. R., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00210 · Cited by 86
Lotz, C., Kelleher, D. K., Gaßner, B., Gekle, M., Vaupel, P. W., & Thews, O. (2007) · Oncology Reports · doi:10.3892/or.17.1.239 · Cited by 85
STRAP Promotes Stemness of Human Colorectal Cancer via Epigenetic Regulation of the NOTCH Pathway
Jin, L., Vu, T., Yuan, G., & Datta, P. K. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0286 · Cited by 85
PI3K Functions in Cancer Progression, Anticancer Immunity and Immune Evasion by Tumors
Dituri, F., Mazzocca, A., Giannelli, G., & Antonaci, S. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/947858 · Cited by 84
Hamilton, D. H., Huang, B., Fernando, R. I., Tsang, K.-Y., & Palena, C. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1894 · Cited by 84
The Multiple Layers of the Tumor Environment
Laplane, L., Duluc, D., Larmonier, N., Pradeu, T., & Bikfalvi, A. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.10.002 · Cited by 84
Therapeutic Targeting of Collective Invasion in Ovarian Cancer
Moffitt, L. R., Karimnia, N., Stephens, A. N., & Bilandzic, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061466 · Cited by 84
A Review on the Effect of Plant Extract on Mesenchymal Stem Cell Proliferation and Differentiation
Saud, B., Malla, R., & Shrestha, K. (2019) · Stem Cells International · doi:10.1155/2019/7513404 · Cited by 84
Terry, S., Buart, S., Tan, T. Z., Gros, G., Noman, M. Z., Lorens, J. B., Mami‐Chouaib, F., Thiery, J. P., & Chouaïb, S. (2017) · OncoImmunology · doi:10.1080/2162402x.2016.1271858 · Cited by 82
Hamaï, A., Meslin, F., Benlalam, H., Jalil, A., Mehrpour, M., Faure, F., Lécluse, Y., Vielh, P., Avril, M., Robert, C., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0719 · Cited by 81
Liu, C. X., Liu, Y., Xie, H., Zhao, S., Xu, X., Fan, L., Guo, X. W., Lu, T., Sun, G., & Ma, X. (2014) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1302 · Cited by 80
Ramachandran, I. R., Condamine, T., Lin, C., Herlihy, S. E., Garfall, A. L., Vogl, D. T., Gabrilovich, D. I., & Nefedova, Y. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.10.040 · Cited by 80
Role of cell adhesion molecules in leukocyte recruitment in the liver and gut
Ala, A., Dhillon, A. P., & Hodgson, H. J. F. (2003) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2003.00235.x · Cited by 79
Xue, X., & Shah, Y. M. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs313 · Cited by 79
Redox Control of Multidrug Resistance and Its Possible Modulation by Antioxidants
Çört, A., Özben, T., Saso, L., Luca, C. D., & Korkina, L. G. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/4251912 · Cited by 79
Min, D., Lu, X., Wang, X., Zhang, B., Meng, W., Yu, F., & Hu, H. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.337 · Cited by 77
Goto, M., Miwa, H., Shikami, M., Imai, N., Suganuma, K., Mizuno, S., Takahashi, M., Mizutani, M., Hanamura, I., & Nitta, M. (2014) · Cancer Investigation · doi:10.3109/07357907.2014.907419 · Cited by 76
New tools to prevent cancer growth and spread: a ‘Clever’ approach
Hollmén, M., Figueiredo, C. R., & Jalkanen, S. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0953-0 · Cited by 76
Basal cell carcinoma: cell of origin, cancer stem cell hypothesis and stem cell markers
Sellheyer, K. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.10158.x · Cited by 74
Loss of the SMRT/NCoR2 Corepressor Correlates with JAG2 Overexpression in Multiple Myeloma
Ghoshal, P., Nganga, A., Moran-Giuati, J., Szafranek, A., Johnson, T. R., Bigelow, A., Houde, C. M., Avet‐Loiseau, H., Smiraglia, D. J., Ersing, N., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3467 · Cited by 73
Intratumoral T Cell Subset Ratios and Fas Ligand Expression on Brain Tumor Endothelium
Yu, J. S., Lee, P. K., Ehtesham, M., Samoto, K., Black, K. L., & Wheeler, C. J. (2003) · Journal of Neuro-Oncology · doi:10.1007/bf02700020 · Cited by 73
Lung Tumor Microenvironment Induces Specific Gene Expression Signature in Intratumoral NK Cells
Gillard, M., Caer, C., Cagnard, N., Crozet, L., Perez, M., Fridman, W. H., Sautès‐Fridman, C., & Cremer, I. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00019 · Cited by 73
CSF1-ETS2-induced microRNA in myeloid cells promote metastatic tumor growth
Mathsyaraja, H., Thies, K., Taffany, D. A., Deighan, C., Liu, T., Yu, L., Fernández, S., Shapiro, C. L., Otero, J. J., Timmers, C. D., et al. (2014) · Oncogene · doi:10.1038/onc.2014.294 · Cited by 70
Regulatory B Cells and Its Role in Central Nervous System Inflammatory Demyelinating Diseases
Ran, Z., Luo, Y., Qiu-Ming, Z., & Yang, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01884 · Cited by 69
Seebacher, N. A., Richardson, D. R., & Jansson, P. J. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13079 · Cited by 67
Chang, H. W., Roh, J., Jeong, E., Lee, S., Kim, S., Choi, S., Park, S., & Kim, S. Y. (2007) · International Journal of Cancer · doi:10.1002/ijc.23069 · Cited by 67
Peppicelli, S., Toti, A., Giannoni, E., Bianchini, F., Margheri, F., Rosso, M. D., & Calorini, L. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1191706 · Cited by 67
She, K.-L., Fang, S., Du, W., Fan, X.-X., He, J.-X., Pan, H., Huang, L.-Y., He, P., & Huang, J. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0809-y · Cited by 67
Pfeifer, C. R., Alvey, C. M., Irianto, J., & Discher, D. E. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.04.005 · Cited by 66
Shah, S. H., Miller, P., García-Contreras, M., Ao, Z., Machlin, L., Issa, E., & El‐Ashry, D. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1071742 · Cited by 65
What Counts in the Immunological Synapse?
Dustin, M. L. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.04.001 · Cited by 65
Chen, Y., Wang, S., Mu, R., Luo, X. G., Liu, Z.-S., Liang, B., Zhuo, H., Hao, X.-P., Wang, Q., Fang, D., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.05.007 · Cited by 65
Kim, B., Stephen, S. L., Hanby, A. M., Horgan, K. J., Perry, S., Richardson, J. L., Roundhill, E. A., Valleley, E. M. A., Verghese, E. T., Williams, B. J., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1625-y · Cited by 64
MAZZIO, E. A., Boukli, N. M., Rivera, N., & Soliman, K. F. A. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02206.x · Cited by 64
Pires, B. R. B., de Amorim, Í. S. S., Souza, L. D. E., Rodrigues, J. A., & Mencalha, A. L. (2016) · Anticancer Research · doi:10.21873/anticanres.11151 · Cited by 64
Abouzahr, S., Bismuth, G., Gaudin, C., Caroll, O., Endert, P. V., Jalil, A., Dausset, J. B., Vergnon, I., Richon, C., Kauffmann, A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510454103 · Cited by 63
MicroRNA-497-5p down-regulation increases PD-L1 expression in clear cell renal cell carcinoma
Qu, F., Ye, J., Pan, X., Wang, J., Gan, S., Chu, C., Chu, J., Zhang, X., Liu, M., He, H., et al. (2018) · Journal of drug targeting · doi:10.1080/1061186x.2018.1479755 · Cited by 61
Therapeutic Targeting of Cancer Stem Cells: Integrating and Exploiting the Acidic Niche
Linden, C. V., & Corbet, C. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00159 · Cited by 61
Stat3 Orchestrates Tumor Development and Progression: The Achilles Heel of Head and Neck Cancers?
Masuda, M., Wakasaki, T., Suzui, M., Toh, S., Joe, A., & Weinstein, I. (2010) · Current Cancer Drug Targets · doi:10.2174/156800910790980197 · Cited by 60
Human leukocyte antigen-G in cancer: Are they clinically relevant?
Yan, W. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.07.019 · Cited by 58
Dysfunctional Mechanotransduction through the YAP/TAZ/Hippo Pathway as a Feature of Chronic Disease
Cobbaut, M., Karagil, S., Bruno, L., de la Loza, M. D. C. D., Mackenzie, F. E., Stolinski, M., & Elbediwy, A. (2020) · Cells · doi:10.3390/cells9010151 · Cited by 57
The Mechanical Microenvironment in Breast Cancer
Pratt, S. J. P., Lee, R., & Martin, S. S. (2020) · Cancers · doi:10.3390/cancers12061452 · Cited by 57
GPER mediated estradiol reduces miR-148a to promote HLA-G expression in breast cancer
Tao, S., He, H., Chen, Q., & Yue, W. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.073 · Cited by 52
Ferrand, N., Gnanapragasam, A., Dorothée, G., Redeuilh, G., Larsen, A. K., & Sabbah, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087878 · Cited by 52
Flati, V., Pastore, L., Griffioen, A. W., Satijn, S., Tomato, E., D’Alimonte, I., LAGLIA, E., Marchetti, P., Gulino, A., & Martinotti, S. (2006) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200601900406 · Cited by 52
Tumors induce the formation of suppressor endothelial cells in vivo
Mulligan, J. K., & Young, M. R. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0747-y · Cited by 49
Duan, Z., Wang, H., Zhao, D., Ji, X., Song, M., Yang, X., & Cui, W. (2015) · Cancer Science · doi:10.1111/cas.12697 · Cited by 48
McLeod, C. M., & Mauck, R. L. (2016) · Scientific Reports · doi:10.1038/srep38852 · Cited by 48
Tumor Microenvironment and Cell Fusion
Jiang, E., Yan, T., Xu, Z., & Shang, Z. (2019) · BioMed Research International · doi:10.1155/2019/5013592 · Cited by 47
Agrawal, V., Maharjan, S., Kim, K., Kim, N., Son, J., Lee, K., Choi, H.-J., Rho, S.-S., Ahn, S., Won, M., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1942 · Cited by 46
Cell Fusion, Drug Resistance and Recurrence CSCs
Nagler, C., Zänker, K. S., & Dittmar, T. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-0782-5_9 · Cited by 45
Yakubenko, V. P., Cui, K., Ardell, C. L., Brown, K. E., West, X. Z., Gao, D., Stefl, S., Salomon, R. G., Podrez, E. A., & Byzova, T. V. (2018) · Blood · doi:10.1182/blood-2017-10-810176 · Cited by 45
The Role of microRNAs in Epithelial Ovarian Cancer Metastasis
Nguyen, V. H. L., Yue, C., Du, K. Y., Salem, M., O’Brien, J. A., & Peng, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197093 · Cited by 44
Regulating Tumor Myeloid-Derived Suppressor Cells by MicroRNAs
Chen, S., Zhang, Y., Kuzel, T. M., & Zhang, B. (2015) · Cancer Cell & Microenvironment · doi:10.14800/ccm.637 · Cited by 43
Zhao, J., Ren, K., & Tang, J. (2014) · Tumor Biology · doi:10.1007/s13277-014-2543-3 · Cited by 42
Salunkhe, S. J., Mishra, S. V., Ghorai, A., Hole, A., Chandrani, P., Dutt, A., Krishna, C. M., & Dutt, S. (2020) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2020.148300 · Cited by 42
MicroRNAs in tumor immunity: functional regulation in tumor-associated macrophages
Chen, C., Liu, J., & Luo, Y. (2019) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1900452 · Cited by 41
Potential approaches for more successful dendritic cell-based immunotherapy
Chiang, C. L.-L., Balint, K., Coukos, G., & Kandalaft, L. E. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1000298 · Cited by 39
Wang, Z., Tan, Y., Yu, W., Zheng, S. S., Zhang, S., Sun, L., & Ding, K. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.17680 · Cited by 39
Ma, S., Jia, R., Li, D., & Shen, B. (2015) · BioMed Research International · doi:10.1155/2015/453986 · Cited by 34
Casós, K., Siguero, L., Fernández‐Figueras, M. T., León, X., Sardá, M.-P., Vila, L., & Camacho, M. (2011) · Microvascular Research · doi:10.1016/j.mvr.2011.01.006 · Cited by 30
Assays of Adenylate Uridylate-Rich Element-Mediated mRNA Decay in Cells
Ysla, R. M., Wilson, G. M., & Brewer, G. (2008) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(08)02403-8 · Cited by 29
Targeting NKG2D in tumor surveillance
Hayakawa, Y. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.681378 · Cited by 26
Unraveling Adipocytes and Cancer Links: Is There a Role for Senescence?
Wu, Q., Li, B., Sun, S., & Sun, S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00282 · Cited by 24
Xi, G., Li, Y. D., Grahovac, G., Rajaram, V., Wadhwani, N. R., Pundy, T., Mania-Farnell, B. L., James, C. D., & Tomita, T. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0593-z · Cited by 24
Kinetics of repression by modified p53 on the PDGF β‐receptor promoter
Yang, W., Wetterskog, D., Matsumoto, Y., & Funa, K. (2008) · International Journal of Cancer · doi:10.1002/ijc.23735 · Cited by 23
Harnessing the stem cell properties of pericytes to repair the brain
Courtney, J., & Sutherland, B. A. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.270301 · Cited by 22
López‐Cobo, S., Romera‐Cárdenas, G., García‐Cuesta, E. M., Reyburn, H. T., & Valés‐Gómez, M. (2015) · Immunology · doi:10.1111/imm.12482 · Cited by 18
Tsai, L., Yu, C.-C., Lo, J., Sung, W., Lee, H., Chen, S.-L., & Chou, M. (2012) · Journal of Dental Sciences · doi:10.1016/j.jds.2012.03.006 · Cited by 17
Oncogenic role of microRNA-20a in human multiple myeloma
Wang, T., Tao, W., Zhang, L., & Li, S. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s143612 · Cited by 14
Qin, X., & Kojima, S. (2019) · Gastrointestinal Disorders · doi:10.3390/gidisord1010014 · Cited by 10
Stem Cells Cycle toward Immune Surveillance
Boyd, A. S., & Rodrigues, N. P. (2018) · Immunity · doi:10.1016/j.immuni.2018.02.006 · Cited by 8
Zhang, T., Chen, H., Zhou, Y., Dong, W., Cai, H., & Tan, W. (2019) · Bioresources and Bioprocessing · doi:10.1186/s40643-019-0249-5 · Cited by 6
miR-125b expression affects tumor growth of multiple myeloma via targeting MKK7.
Jiang, Y., Luan, Y., He, D., & Chen, G. (2017) · PubMed · Cited by 5
Cited by
(2023) · doi:10.1038/s41392-022-01304-4 · Cited by 460
Unveiling the mechanisms and challenges of cancer drug resistance
Khan, S. U., Fatima, K., Aisha, S., & Malik, F. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01302-1 · Cited by 417
Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance
Neophytou, C. M., Trougakos, I. P., Erin, N., & Papageorgis, P. (2021) · Cancers · doi:10.3390/cancers13174363 · Cited by 371
Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches
Tufail, M., Jiang, C.-H., & Li, N. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02280-1 · Cited by 363
Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells
Garg, P., Malhotra, J., Kulkarni, P., Horne, D., Salgia, R., & Singhal, S. S. (2024) · Cancers · doi:10.3390/cancers16132478 · Cited by 339
“Dysregulated signaling pathways such as PI3K/Akt/mTOR, MAPK/ERK, and Wnt/ β -catenin contribute to drug resistance and are targets for therapeutic interventions [101].”
Background
Metadata
- Authors
- Khalaf, K., Hana, D., Chou, J. T.-T., Singh, C., Mackiewicz, A., & Kaczmarek, M.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2021-05-27
- Volume
- 12
- Pages
- 656364-656364
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3170943164
- Cited by
- 513
- References
- 490
- FWCI
- 24.87
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.